Skip to main content

Brosius Mark's Form 4 filing

Intuitive Surgical Inc (ISRG) · filed Mar 5, 2026

Accession no.
0002010300-26-000011
Filed
Mar 5, 2026
Trade date
Mar 3-5, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions. Open-market sales total $1.82M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Brosius MarkCIK 0002010300Officer (SVP & Chief Mfg and Supply Cha)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2026Common StockSSaleDisposed−648$488.10F2−$316,288.85,916Direct
Mar 4, 2026Common StockSSaleDisposed−2,362$498.68F3−$1,177,882.163,554Direct
Mar 5, 2026Common StockSSaleDisposed−648$495.20−$320,889.62,906Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $487.18 to $489.94 as follows: 432 shares sold at $487.18 and 216 shares sold at $489.94. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $495.19 to $500.00 as follows: 648 shares sold at $495.19 and 1,714 shares sold at $500.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)